摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-(3',5'-Di-O-benzyl-β-D-erythro-pent-2-enofuranosyl)-1-benzylhypoxanthine | 136852-24-9

中文名称
——
中文别名
——
英文名称
9-(3',5'-Di-O-benzyl-β-D-erythro-pent-2-enofuranosyl)-1-benzylhypoxanthine
英文别名
1-benzyl-9-[(2R,5R)-4-phenylmethoxy-5-(phenylmethoxymethyl)-2,5-dihydrofuran-2-yl]purin-6-one
9-(3',5'-Di-O-benzyl-β-D-erythro-pent-2-enofuranosyl)-1-benzylhypoxanthine化学式
CAS
136852-24-9
化学式
C31H28N4O4
mdl
——
分子量
520.588
InChiKey
KGUGHVJJNCIYKX-VSGBNLITSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    39
  • 可旋转键数:
    10
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    78.2
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    3',5'-Di-O-benzyl-N1-benzylinosine吡啶二乙胺基三氟化硫 作用下, 以 二氯甲烷 为溶剂, 以41%的产率得到9-(3',5'-Di-O-benzyl-β-D-erythro-pent-2-enofuranosyl)-1-benzylhypoxanthine
    参考文献:
    名称:
    A synthesis of 9-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)adenine and -hypoxanthine. An effect of C3'-endo to C2'-endo conformational shift on the reaction course of 2'-hydroxyl group with DAST
    摘要:
    O3',O5',N6-Tritrityladenosine (6), 3',5'-di-O-trityl-N1-benzylinosine (15), and 3',5'-di-O-tritylinosine (18) were prepared and subjected to nucleophilic reaction with DAST. Thus, 6 afforded 2'-beta-fluorine-substituted nucleoside 11 along with the isomeric 2-deoxy-2-(N-trityladenin-3-yl)-3,5-di-O-trityl-alpha-D-arabinofuranosyl fluoride (12). Nucleoside 15, under the same treatment with DAST, gave the desired 2'-fluoroarabino derivative 16 exclusively in high yield. Although 18 was converted into the 2'-beta-fluoro product 19 under the similar conditions, the yield was low. A plausible mechanism of formation of 12 is discussed. Deprotection of 11 and 16 afforded the desired 9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine (1) and -hypoxanthine (2), respectively, in high yield. The conformational influence of sugar protecting groups on the rate of nucleophilic substitution against elimination is discussed. Treatment of O3',O5',N1-benzylinosine (20) with DAST afforded only the elimination products 9-(3',5'-di-O-benzyl-beta-D-erythro-pent-2-enofuranosyl)-1-benzylhypoxanthine (22) and 3-(benzyloxy)-2-[(benzyloxy)methyl]furan (23). On the other hand, 9-(3,5-di-O-trityl-beta-D-arabinofuranosyl)adenine (26) (prepared from 6 by triflyation followed by NaOAc treatment and deacetylation) afforded a mixture from which 2'-deoxy-2'-fluoroadenosine (27) and 9-(2-deoxy-3,5-di-O-trityl-D-erythro-pent-1-enofuranosyl)-N6-trityladenine (28) were isolated in 60 and 30% yield, respectively. O2',O5',N6-Tritrityladenosine (7) was selectively detritylated with HCO2H/Et2O to give O2',N6-ditrityladenosine (30), which, upon treatment with benzyl chloride/KOH, afforded 3',5'-di-O-benzyl-O2',N6-ditrityladenosine (31). 9-(3,5-Di-O-benzyl-beta-D-arabinofuranosyl)adenine (35) was prepared from 31 by further detritylation with CF3CO2H/CHCl3 and triflyation followed by NaOAc treatment and deacetylation of the product. Treatment of 35 with DAST followed by hydrogenolytic debenzylation afforded 2'-deoxy-2'-fluoroadenosine (3) in high yield. The three-step synthesis described herein, albeit about 10% overall yield, is far superior to the currently available multistep procedures which give the desired 2'-fluoroarabinosylpurines in much less overall yields.
    DOI:
    10.1021/jo00028a030
点击查看最新优质反应信息

文献信息

  • KRZEMINSKI, JACEK;NAWROT, BARBARA;PANKIEWICZ, KRZYSZTOF W.;WATANABE, KYOI+, NUCLEOSIDES AND NUCLEOTIDES, 10,(1991) N, C. 781-798
    作者:KRZEMINSKI, JACEK、NAWROT, BARBARA、PANKIEWICZ, KRZYSZTOF W.、WATANABE, KYOI+
    DOI:——
    日期:——
查看更多

同类化合物

马来酸恩替卡韦 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 阿巴卡韦羧酸盐 阿巴卡韦相关物质D 阿巴卡韦杂质F 阿巴卡韦杂质 阿巴卡韦中间体A5 阿巴卡韦5’-磷酸酯 阿巴卡韦,拉米夫定混合物 阿巴卡韦 阿巴卡韦 铁(2+)乙二酸酯-丁烷-1-胺(1:1:2) 贝伐西尼 苯甲酸,3-(2-氨基-2-氰基乙酰基)-,乙基酯 芒霉素 艾夫他滨 腺苷基(3'-5')胞苷基(3'-5')胞苷游离酸 腺苷-3',5'-环硫代磷酸酯 腺苷-2',3'-环单硫代磷酸酯,盐内/RP-同质异能素钠 脱氧假尿苷 胸苷酰-(5'-3')-胸苷酰-(5'-3')-胸苷酰-(5'-3')-5'-胸苷酸 胰腺癌RX-3117 硫酸阿巴卡韦 甲基磷羧酸氢[(2S,5R)-5-(4-氨基-2-羰基嘧啶-1(2H)-基)-2,5-二氢呋喃-2-基]甲酯 瓶型酵母D 瓶型酵母A 环戊烯基尿嘧啶 水杨酸拉米呋啶 氟达拉滨EP杂质H 曲沙他滨 拉米夫定相关化合物(Α-TROXACITABINE) 拉米夫定杂质Ⅲ1-[(2R,5S)-2-羟甲基-1,3-氧硫杂环戊-5-基]-嘧啶-2,4(1H,3H)-酮 拉米夫定杂质27 拉米夫定杂质1 拉米夫定单磷酸铵盐 拉米夫定二磷酸酯铵盐 拉米夫定S-氧化物(异构体混合物) 拉米夫定 拉米夫定 拉夫米定EP杂质J 拉夫米定EP杂质H 扎西他宾 恩替卡韦相关物质A 恩替卡韦杂质SSS 恩替卡韦一水合物 恩曲他滨杂质16 恩曲他滨S-氧化物